pharmathene inc (PIP:NYSE Amex)
John M. Gill CPA
Chief Executive Officer, President, Director, Chairman of Audit Committee and Member of Compensation Committee, PharmAthene, Inc.
|Age||Total Calculated Compensation||This person is connected to 51 board members in 3 different organizations across 4 different industries.|
See Board Relationships
Mr. John M. Gill, CPA has been the Chief Executive Officer and President of Pharmathene, Inc. since March 12, 2015. Mr. Gill co-founded Tetralogic Pharmaceuticals, Inc. in 2003 and served as its President and Chief Executive Officer until August 12, 2013. Mr. Gill held senior management positions in operations and finance at SmithKline Beecham Corporation and 3 Dimensional Pharmaceuticals. Mr. Gill served as the Chief Financial Officer of 3-dimensional Pharmaceuticals ...
One Park PlacePhone: 410-269-2600
Annapolis, Maryland 21401
Board Members Memberships*
Former Chief Operating Officer, Executive Vice President and Director
Chief Executive Officer, President, Director, Chairman of Audit Committee and Member of Compensation Committee
Rutgers, The State University of New Jersey
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Marijn E. Dekkers Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Moshe Manor||Chief Executive Officer, President and Director|
Protalix BioTherapeutics, Inc.
|$93.7K||Compensation as of Fiscal Year 2014.|